Stay updated on Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Baricitinib in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 replaces the previous Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.4.2 and the old government funding status notice and Revision: v3.4.1 have been removed, which are administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center operating status was added. Revision: v3.4.1.SummaryDifference0.2%

- Check49 days agoChange DetectedGlossary is now displayed on the page, improving terminology clarity. QC-related labels have been updated and the release notes show Revision: v3.4.0, with minor wording changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive changes to the study details are evident.SummaryDifference0.0%

- Check85 days agoChange DetectedThe Locations section was updated to reflect participating sites with a new revision (v3.3.3); older location entries (v3.3.2) have been removed.SummaryDifference2%

Stay in the know with updates to Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Baricitinib in Atopic Dermatitis Clinical Trial page.